Search research articles
Contact Us
Filters
Showing results (61-70 of 210) with videos related to
Page
of 21
Sort By:
Journal for Immunotherapy of Cancer
|
October 6, 2020
Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC
Alissa Keegan, Biagio Ricciuti, Padric Garden, et al.
International Journal of Cancer
|
March 7, 2020
Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer
Matthew D Hellmann, Scott Gettinger, Laura Q M Chow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2018
Safety of Programmed Death-1 Pathway Inhibitors Among Patients With Non-Small-Cell Lung Cancer and Preexisting Autoimmune Disorders
Giulia C Leonardi, Justin F Gainor, Mehmet Altan, et al.
Clinical Lung Cancer
|
February 22, 2025
Association of Sarcopenia With Toxicity and Survival in Patients With Lung Cancer, a Multi-Institutional Study With External Dataset Validation
Anurag Saraf, John He, Kee-Young Shin, et al.
Cancer Immunology Research
|
February 12, 2016
Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer
Mizuki Nishino, Emily S Chambers, Curtis R Chong, et al.
Nature Communications
|
June 14, 2024
Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers
Taek-Chin Cheong, Ahram Jang, Qi Wang, et al.
Cancer Immunology Research
|
March 2, 2017
Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
Guillermo De Velasco, Youjin Je, Dominick Bossé, et al.
JCO Precision Oncology
|
September 3, 2021
Characterization of Non-Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment Patterns
Jessica K Lee, Russell Madison, Anthony Classon, et al.
HGG Advances
|
June 21, 2024
Additional impact of genetic ancestry over race/ethnicity to prevalence of KRAS mutations and allele-specific subtypes in non-small cell lung cancer
Xinan Wang, Kangcheng Hou, Biagio Ricciuti, et al.
Frontiers in Oncology
|
April 16, 2019
Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated With Anti-PD-1 Therapy
Muhammad Mohsin Fareed, Luke R G Pike, Andrew Bang, et al.
Page
of 21
Search research articles
Search
Showing results (61-70 of 210) with videos related to
Sort By:
Page
of 21
Journal for Immunotherapy of Cancer
|
October 6, 2020
Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC
Alissa Keegan, Biagio Ricciuti, Padric Garden, et al.
International Journal of Cancer
|
March 7, 2020
Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer
Matthew D Hellmann, Scott Gettinger, Laura Q M Chow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2018
Safety of Programmed Death-1 Pathway Inhibitors Among Patients With Non-Small-Cell Lung Cancer and Preexisting Autoimmune Disorders
Giulia C Leonardi, Justin F Gainor, Mehmet Altan, et al.
Clinical Lung Cancer
|
February 22, 2025
Association of Sarcopenia With Toxicity and Survival in Patients With Lung Cancer, a Multi-Institutional Study With External Dataset Validation
Anurag Saraf, John He, Kee-Young Shin, et al.
Cancer Immunology Research
|
February 12, 2016
Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer
Mizuki Nishino, Emily S Chambers, Curtis R Chong, et al.
Nature Communications
|
June 14, 2024
Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers
Taek-Chin Cheong, Ahram Jang, Qi Wang, et al.
Cancer Immunology Research
|
March 2, 2017
Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
Guillermo De Velasco, Youjin Je, Dominick Bossé, et al.
JCO Precision Oncology
|
September 3, 2021
Characterization of Non-Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment Patterns
Jessica K Lee, Russell Madison, Anthony Classon, et al.
HGG Advances
|
June 21, 2024
Additional impact of genetic ancestry over race/ethnicity to prevalence of KRAS mutations and allele-specific subtypes in non-small cell lung cancer
Xinan Wang, Kangcheng Hou, Biagio Ricciuti, et al.
Frontiers in Oncology
|
April 16, 2019
Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated With Anti-PD-1 Therapy
Muhammad Mohsin Fareed, Luke R G Pike, Andrew Bang, et al.
Page
of 21